Beth Hecht, Director at Neos Therapeutics, holds 1.35M shares in Xeris Pharmaceuticals (Ticker: XERS), holds 18.84K shares in Iterum Therapeutics (Ticker: ITRM), holds 9.05K shares in Aytu BioScience (Ticker: AYTU). Most recently, Beth Hecht Sold ― shares of Xeris Pharmaceuticals on Mar 21, 2025 for an estimated value of 217.20K.
What is the percentage of profitable transactions made by Beth Hecht?
The percentage of profitable transactions made by Beth Hecht is 75%.
What is the average return per transaction made by Beth Hecht?
The average return per transaction made by Beth Hecht is 47.60%.
What stocks does Beth Hecht hold?
Beth Hecht holds: NEOS, XERS, ITRM, AYTU stocks.
What was Beth Hecht’s latest transaction?
Beth Hecht latest transaction was an Informative Sell of $217.20K.
What was Beth Hecht's most profitable transaction?
Beth Hecht’s most profitable transaction was an Informative Buy of XERS stock on March 16, 2020. The return on the trade was 200.00%.
What is Beth Hecht's role in Neos Therapeutics?
Beth Hecht's role in Neos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.